{"database": "lobbying", "table": "lobbying_activities", "rows": [[1736877, "8647783b-df86-440e-bab8-c7c2466a2583", "Q3", "EMPIRE CONSULTING GROUP", 400703105, "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA", 2015, "third_quarter", "PHA", "Medicare Prescription Drug Act; HR 9, Innovation Act; 21st Century Cures Act; prescription drug costs; Trans Pacific Partnership (TPP) Agreement (provisions relating to data protection for biologics);and budget reconciliation legislation (provisions relating to healthcare).", "HOUSE OF REPRESENTATIVES", 40000, null, 0, 0, "2015-10-18T21:31:16.157000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1736877"], "units": {}, "query_ms": 3.8491140003316104, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}